JBM Healthcare : CHANGE OF COMPLIANCE ADVISER

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

JBM (HEALTHCARE) LIMITED

健倍苗苗（保健）有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2161)

CHANGE OF COMPLIANCE ADVISER

This announcement is made by JBM (Healthcare) Limited (the "Company") pursuant to Rule 3A.29 of the Rules (the "Listing Rules") Governing the Listing of Securities on the Main Board of The Stock Exchange of Hong Kong Limited (the "Stock Exchange").

The board (the "Board") of directors (the "Directors") of the Company announces that the Company and Pine Peak Corporate Finance Limited ("Pine Peak") have mutually agreed to terminate the compliance adviser agreement entered into between the two parties dated 4 December 2020 (the "Termination") due to key personnel changes at Pine Peak which will undermine the capacity of Pine Peak in providing satisfactory compliance advisory service to the Company. The Termination will take effect on 30 April 2021.

Saved as disclosed in this announcement, each of the Board and Pine Peak confirms that, as of the date of this announcement, there are no other matters relating to the Termination that need to be drawn to the attention of the shareholders of the Company and the Stock Exchange.

The Board further announces that Ping An of China Capital (Hong Kong) Company Limited ("Ping An of China Capital") has been appointed as the new compliance adviser to the Company as required pursuant to Rule 3A.27 of the Listing Rules with effect from 30 April 2021 until the date on which the Company complies with Rule 13.46 of the Listing Rules in respect of its financial results for the year ending 31 March 2022 in respect of Rule 3A.19 of the Listing Rules; or until the compliance adviser agreement entered into between the Company and Ping An of China Capital is terminated in accordance with its terms, whichever is earlier.

- 1 -

Ping An of China Capital is a licensed corporation under the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) to carry out Type 6 (advising on corporate finance) regulated activities.

By Order of the Board

JBM (Healthcare) Limited

Wong Yat Wai, Patrick

Executive Director and Chief Executive Officer

Hong Kong, 30 April 2021

As at the date of this announcement, the Board comprises Mr. Sum Kwong Yip, Derek (as the Chairman and non-executive Director), Mr. Wong Yat Wai, Patrick (also as Chief Executive Officer) and Dr. Chu Ka Wing as executive Directors, Mr. Yim Chun Leung and Mr. Yeung Kwok Chun, Harry as non-executive Directors, and Mr. Chan Kam Chiu, Simon, Mr. Luk Ting Lung, Alan and Mr. Lau Shut Lee, Tony as independent non-executive Directors.

- 2 -